Hitting Your Consumer Through Linear and CTV

 
Today’s technology provides many options for those wanting to reach audiences
through TV. Linear TV is no longer the only option; CTV, or connected television,
continues to spread as more and more consumers cut the cord of traditional linear
options and move to internet streaming content. Estimates indicate the bulk of television
viewership will move to digital by 2024.

No matter the channel, there is much potential to reach consumers through linear and
CTV. Whether selling a product on demand, creating brand awareness, or driving retail,
TV is the best way to get the most eyeballs for the smallest amount of money to drive
retail foot traffic.

Christine Russo of What Just Happened? is always on the hunt for the latest insights
and trends in retail. To get the scoop on the exciting happenings in linear and CTV, she
connected with Stacy Durand, CEO of Media Design Group. MDG specializes in
utilizing Smart Media to bring the precision of digital advertising with the reach of TV to
grow the next generation of audience activation.

Stacy Durand plays a central role in redefining and shaping the future of media buying
and performance video advertising through her leadership with Smart Media
Technologies. Durand leverages deep expertise in every facet of the DTC industry and
has managed billions of dollars in television budgets, helping clients drive tens of
billions in revenue.

Durand and Russo discuss:

• Why retailers should consider looking at linear and CTV media opportunities

• Understanding the dynamics within performance video

• The affordability of TV advertising and analytics available to track results

“Most of our clients are D2C,” Durand said. “We’ve gotten more non-D2C clients since
the pandemic. Part of the reason for that is they wanted flexibility. There are quite a few
companies that were stuck in their advertising budgets. Things were closed during the
pandemic, yet they had advertising commitments. We offer flexibility. We buy a lot of
time on connected TV, OTT devices, and linear. But we can get a very low rate, yet
cancel and move budgets around.”

“Connected TV, streaming TV, is data-driven,” Durand said. “Linear is efficiency. They
work together well, and they inform each other really well. In CTV, we can load in our
audience segments, and the ad is served to folks in our audience.”

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More